Charles River Laboratories | CRL - Sales Revenues



Charles River Laboratories reported $1.03B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Agilent USD 1.74B 68M Jul/2025
Align Technology USD 1.01B 30.7M Jun/2025
Bio-Rad Laboratories USD 651.6M 66.2M Jun/2025
Bruker USD 797.4M 4M Jun/2025
Cardinal Health USD 60.2B 5.3B Jun/2025
Charles River Laboratories USD 1.03B 45.8M Jun/2025
Cigna USD 67.2B 1.7B Jun/2025
CVS Health USD 98.9B 4.3B Jun/2025
Danaher USD 5.94B 200M Jun/2025
Dentsply International USD 936M 57M Jun/2025
Elevance Health 49.4B 600M Jun/2025
Galapagos EUR 70.17M 4.81M Jun/2025
Hologic USD 1.02B 10M Jun/2025
Humana USD 32.39B 280M Jun/2025
Illumina USD 1.06B 20M Jun/2025
Incyte USD 1.06B 10M Jun/2025
IQVIA Holdings USD 4.02B 190M Jun/2025
Laboratory Of America USD 3.53B 180M Jun/2025
Lonza CHF 3.58B 63M Jun/2025
McKesson USD 97.83B 7.01B Jun/2025
Merck EUR 4.43B 850M Jun/2025
Mettler Toledo International USD 983.22M 99.48M Jun/2025
Novartis USD 14.05B 821M Jun/2025
Pfizer USD 14.7B 980M Jun/2025
Quest Diagnostics USD 2.76B 110M Jun/2025
Revvity USD 720M 55M Jun/2025
Thermo Fisher Scientific USD 10.85B 490M Jun/2025
United Therapeutics USD 798.6M 4.2M Jun/2025
UnitedHealth 111.62B 2.02B Jun/2025
Waters USD 771M 109M Jun/2025
West Pharmaceutical Services USD 766.5M 68.5M Jun/2025